Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Charizanis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neuroscience Letters|August 4, 2009
Pathogenic RNAs in microsatellite expansion diseaseJihae Shin, Konstantinos Charizanis, Maurice S Swanson
Human Molecular Genetics|April 7, 2010
Partners in crime: bidirectional transcription in unstable microsatellite diseaseRanjan Batra, Konstantinos Charizanis, Maurice S Swanson
Cold Spring Harbor Perspectives in Biology|November 19, 2010
Developments in RNA splicing and diseaseMichael G Poulos, Ranjan Batra, Konstantinos Charizanis, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 26, 2026
Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 TrialsJay S Pepose, Shane Foster, Christopher Pearson, et al.
Ophthalmology|September 18, 2024
Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic SolutionJay S Pepose, David Wirta, David Evans, et al.
Molecular Cell|September 30, 2014
Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated diseaseRanjan Batra, Konstantinos Charizanis, Mini Manchanda, et al.
BMC Ophthalmology|October 8, 2022
A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbancesJay Pepose, Mitchell Brigell, Eliot Lazar, et al.
EMBO Molecular Medicine|December 3, 2013
Compound loss of muscleblind-like function in myotonic dystrophyKuang-Yung Lee, Moyi Li, Mini Manchanda, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|February 26, 2021
Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b TrialPaul M Karpecki, Shane A Foster, Stephen M Montaquila, et al.
Cell Reports|August 11, 2015
MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy BrainMarianne Goodwin, Apoorva Mohan, Ranjan Batra, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neuroscience Letters|August 4, 2009
Pathogenic RNAs in microsatellite expansion diseaseJihae Shin, Konstantinos Charizanis, Maurice S Swanson
Human Molecular Genetics|April 7, 2010
Partners in crime: bidirectional transcription in unstable microsatellite diseaseRanjan Batra, Konstantinos Charizanis, Maurice S Swanson
Cold Spring Harbor Perspectives in Biology|November 19, 2010
Developments in RNA splicing and diseaseMichael G Poulos, Ranjan Batra, Konstantinos Charizanis, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 26, 2026
Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 TrialsJay S Pepose, Shane Foster, Christopher Pearson, et al.
Ophthalmology|September 18, 2024
Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic SolutionJay S Pepose, David Wirta, David Evans, et al.
Molecular Cell|September 30, 2014
Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated diseaseRanjan Batra, Konstantinos Charizanis, Mini Manchanda, et al.
BMC Ophthalmology|October 8, 2022
A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbancesJay Pepose, Mitchell Brigell, Eliot Lazar, et al.
EMBO Molecular Medicine|December 3, 2013
Compound loss of muscleblind-like function in myotonic dystrophyKuang-Yung Lee, Moyi Li, Mini Manchanda, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|February 26, 2021
Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b TrialPaul M Karpecki, Shane A Foster, Stephen M Montaquila, et al.
Cell Reports|August 11, 2015
MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy BrainMarianne Goodwin, Apoorva Mohan, Ranjan Batra, et al.
Pageof 2